Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol vs. Valproate for Agitation in ED
NCT01750541Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of valproic acid in psychomotor agitation (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Agitated Behavior Scale at 30 months. Started Dec 2012; status: completed.
02
Drugs
valproic acid
03
Conditions
psychomotor agitation
Beyond the preview
Go deeper on NCT01750541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01750541.